Sovereign Capital Partners, a UK private equity firm, has acquired healthcare-at-home service provider Apollo Home Healthcare. Apollo is a primary provider of nurse-led complex care at home for individuals eligible for NHS Continuing Healthcare (CHC) funding. It provides personalised high-acuity care, with a focus on children and adults with complex clinical needs, acting as a commissioned provider for the NHS to deliver care packages that are fully funded by the health service.
Archives
Hims & Hers acquires Australian digital health platform Eucalyptus
Hims & Hers, the US-based telehealth platform, has acquired Australian digital health platform Eucalyptus in a US$1.15 billion deal, its largest acquisition to date.
February 26, 2026
Ramsay proposes to spin off French hospital subsidiary Santé via in-specie share distribution
Ramsay Health Care, Australia’s largest private hospital group, has announced plans to separate its European arm, Ramsay Santé, by distributing its shares directly to its existing shareholders through an in-specie distribution.
February 24, 2026
Private capital can drive R&D in personalised patient care technology — Andrew Earnshaw, PA Consulting
HBI spoke to PA Consulting’s digital healthcare expert, Andrew Earnshaw, about what the gap between NHS infrastructure and the growing demand for preventative care means for private healthcare and where the opportunity for private capital lies.
February 23, 2026
Hayfin leads Alantra’s €155m CV for genomics company Health in Code
Alantra, a Spanish private equity firm focused on mid-market transactions, has closed a €155 million healthcare continuation fund to support the next phase of growth at Health in Code (HiC), a clinical genomics company it has backed since 2020. The fund was oversubscribed and led by Hayfin Capital Management, a London-headquartered lending firm, alongside other […]
February 19, 2026
Genesis Capital buys Czech outpatient rehabilitation service provider Fyzioterapie s úsměvem
Genesis Capital, a private equity firm focused on small and medium-sized companies in Central Europe, has acquired a majority stake in a private outpatient rehabilitation service provider in the Czech Republic, Fyzioterapie s úsměvem.
February 19, 2026
GRO Capital exits audiology software provider Auditdata
Northern European private equity firm GRO Capital has exited Auditdata, an audiology software provider for hearing care, after ten years.
February 19, 2026
Ampersand Capital Partners buys Purna Pharmaceuticals
Ampersand Capital Partners, a life sciences and healthcare-focused private equity firm, has acquired Purna Pharmaceuticals, a Belgian contract development and manufacturing service provider (CDMO) for liquid and semi-solid medicines for pharmaceutical companies, from alternative investment fund manager Creafund.
February 19, 2026
Essity secures €400 million financing from European Investment Bank
Sweden-headquartered health and hygiene company Essity has recently secured €400 million in financing from the European Investment Bank, the lending arm of the European Union.
February 12, 2026
CVC buys out dsm-firmenich’s animal health & nutrition business for €2.2 billion
Global private equity firm CVC has purchased the animal health and nutrition (ANH) business of Dutch-Swiss nutrition company dsm-firmenich for €2.2 billion.
February 12, 2026
Juvisé Pharmaceuticals secures €550 refinancing from Hayfin Capital Management
Juvisé, a France-based speciality pharmaceutical company focusing on essential medicines, has secured €550 million in refinancing from investment firm Hayfin. The financing includes €400 million of existing debt and a new €150 million line for capital expenditure, focusing on future M&A opportunities.
February 12, 2026
Healthscope to be restructured into a not-for-profit organisation
Lenders of Australia’s second-largest private hospital operator, Healthscope, have now approved a plan to restructure the group into a not-for-profit organisation following its liquidation process.
